SKI Market

A+| A| A-|

Indian Indices

Sensex

76,886.91 -416.72
( -0.54%)

Global Indices

Nasdaq

49,198.35 -53.37
(-0.11%)

Dow Jones

7,195.79 9.71
(0.14%)

Hang Seng

59,839.06 -698.30
(-1.15%)

Nikkei 225

10,331.11 -47.97
(-0.46%)

Forex

USD-INR

93.91 -0.14
(-0.15%)

EUR-INR

110.02 0.03
(0.03%)

GBP-INR

127.00 0.16
(0.13%)

JPY-INR

0.59 0.00
(-0.03%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Industry :

BSE Code

ISIN Demat

Book Value()

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

EPS(TTM)

Face Value()

Div & Yield %

Back

Gland Pharma receives USFDA approval for Brimonidine Tartrate Ophthalmic Solution, 0.025%

Mar 04,2026

Gland Pharma has received tentative approval from the United States Food and Drug Administration (USFDA) for its Abbreviated New Drug Application filed for Brimonidine Tartrate Ophthalmic Solution, 0.025% (OTC).

The Product is bioequivalent and therapeutically equivalent to the reference listed drug (RLD), Lumify Ophthalmic Solution, 0.025%, of Bausch & Lomb Inc.

This Product is indicated to relieve redness of the eye.

76,886.91 -416.72 ( -0.54%)

49,198.35 -53.37 (-0.11%)

7,195.79 9.71 (0.14%)

59,839.06 -698.30 (-1.15%)

10,331.11 -47.97 (-0.46%)

93.91 -0.14 (-0.15%)

110.02 0.03 (0.03%)

127.00 0.16 (0.13%)

0.59 0.00 (-0.03%)